BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11238586)

  • 21. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
    Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
    Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites.
    Rangarajan S; He Y; Chen Y; Kerzic MC; Ma B; Gowthaman R; Pierce BG; Nussinov R; Mariuzza RA; Orban J
    J Biol Chem; 2018 Oct; 293(41):15991-16005. PubMed ID: 30135211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):445-57. PubMed ID: 8183283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
    Höllsberg P; Weber WE; Dangond F; Batra V; Sette A; Hafler DA
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4036-40. PubMed ID: 7732026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors.
    Baker BM; Ding YH; Garboczi DN; Biddison WE; Wiley DC
    Cold Spring Harb Symp Quant Biol; 1999; 64():235-41. PubMed ID: 11232291
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.
    Piepenbrink KH; Borbulevych OY; Sommese RF; Clemens J; Armstrong KM; Desmond C; Do P; Baker BM
    Biochem J; 2009 Oct; 423(3):353-61. PubMed ID: 19698083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.
    Pentcheva T; Edidin M
    J Immunol; 2001 Jun; 166(11):6625-32. PubMed ID: 11359816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
    Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
    J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not just another Fab: the crystal structure of a TcR-MHC-peptide complex.
    Jardetzky T
    Structure; 1997 Feb; 5(2):159-63. PubMed ID: 9032079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.
    Baker BM; Gagnon SJ; Biddison WE; Wiley DC
    Immunity; 2000 Oct; 13(4):475-84. PubMed ID: 11070166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.
    Garboczi DN; Utz U; Ghosh P; Seth A; Kim J; VanTienhoven EA; Biddison WE; Wiley DC
    J Immunol; 1996 Dec; 157(12):5403-10. PubMed ID: 8955188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How an alloreactive T-cell receptor achieves peptide and MHC specificity.
    Wang Y; Singh NK; Spear TT; Hellman LM; Piepenbrink KH; McMahan RH; Rosen HR; Vander Kooi CW; Nishimura MI; Baker BM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4792-E4801. PubMed ID: 28572406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
    Utz U; Koenig S; Coligan JE; Biddison WE
    J Immunol; 1992 Jul; 149(1):214-21. PubMed ID: 1607654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
    Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
    J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of class I MHC regions which bind to the adenovirus E3-19k protein.
    Flomenberg P; Gutierrez E; Hogan KT
    Mol Immunol; 1994 Nov; 31(16):1277-84. PubMed ID: 7969188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
    Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
    J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.